Product Name:1-(3,4-Dimethoxyphenyl)ethanone

IUPAC Name:1-(3,4-dimethoxyphenyl)ethan-1-one

CAS:1131-62-0
Molecular Formula:C10H12O3
Purity:98%
Catalog Number:CM247812
Molecular Weight:180.2

Packing Unit Available Stock Price($) Quantity
CM247812-500g in stock Ÿdž

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1131-62-0
Molecular Formula:C10H12O3
Melting Point:-
Smiles Code:CC(C1=CC=C(OC)C(OC)=C1)=O
Density:
Catalog Number:CM247812
Molecular Weight:180.2
Boiling Point:287°C at 760 mmHg
MDL No:MFCD00008737
Storage:Store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Cabozantinib
On August 21, 2023, Exelixis and Ipsen announced that the global phase 3 CONTACT-02 study of cabozantinib (Cabometyx ®) in combination with atezolizumab for metastatic castration-resistant prostate cancer (mCRPC) met the primary endpoint of progression-free survival (PFS) in an interim analysis.
Prostate cancer is the fourth most common cancer worldwide and the second most common cancer among men. At present, the drugs approved for the treatment of CRPC are basically AR inhibitors or PARP inhibitors, and the combination therapy of Cabozantinib + Atezolizumab is expected to become a new treatment option for such patients.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.